image
Healthcare - Biotechnology - NASDAQ - US
$ 9.4
-15.3 %
$ 1.07 B
Market Cap
-2.97
P/E
BALANCE SHEET
691 M ASSETS
318.72%
61.4 M LIABILITIES
-16.80%
630 M EQUITY
589.92%
BALANCE SHEET DECOMPOSITION
Balance Sheet Dyne Therapeutics, Inc.
image
Current Assets 659 M
Cash & Short-Term Investments 642 M
Receivables 0
Other Current Assets 17 M
Non-Current Assets 32 M
Long-Term Investments 0
PP&E 30 M
Other Non-Current Assets 1.94 M
92.92 %4.34 %Total Assets$691.2m
Current Liabilities 42.3 M
Accounts Payable 6.56 M
Short-Term Debt 4.85 M
Other Current Liabilities 30.8 M
Non-Current Liabilities 19.1 M
Long-Term Debt 0
Other Non-Current Liabilities 19.1 M
10.69 %7.90 %50.24 %31.17 %Total Liabilities$61.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007
ASSETS
Cash & Cash Equivalents 435.4 121.6 172.1 200.8 300.9 14.6 8.1 365.0 1 776.0 505.0 1 870.0 843.0 348.0 396.0 291.0 471.0 693.0 328.0
Short Term Investments 206.8 1.5 83.9 175.7 44.5 0 0 32.0 130.0 100.0 78.0 25.0 13.0 69.0 106.0 78.0 87.0 104.0
Receivables 0 0 0 0 0 0 0 513.0 386.0 402.0 270.0 420.0 108.0 6.0 230.0 212.0 340.0 426.0
Inventory 0 0 0 0 0 0 0 445.0 445.0 597.0 208.0 181.0 101.0 57.0 121.0 141.0 184.0 199.0
Other Current Assets 17.0 6.3 9.6 11.6 7.5 0.3 34 K 169.0 250.0 341.0 248.0 216.0 473.0 144.0 1 496.0 1 136.0 1 499.0 606.0
Total Current Assets 659.3 129.4 256.0 382.4 345.3 14.8 8.2 1 524.0 2 987.0 1 945.0 2 674.0 1 685.0 1 043.0 672.0 2 244.0 2 038.0 2 803.0 1 663.0
PP&E 30.0 33.4 38.4 41.0 1.9 1.5 0.1 8 884.0 7 121.0 8 347.0 3 255.0 3 315.0 3 022.0 3 334.0 6 273.0 9 071.0 10 869.0 10 689.0
Intangible Assets 0 0 0 0 0 0 0 25.0 38.0 102.0 27.0 108.0 271.0 0 141.0 380.0 437.0 497.0
Goodwill 0 0 0 0 0 0 0 772.0 799.0 797.0 0 0 0 0 0 0 433.0 438.0
Long Term Investments 0 0 2.3 2.3 2.3 0 0 26.0 16.0 18.0 2.0 11.0 0 0 0 0 0 0
Other Long Term Assets 1.9 2.3 9.6 0 3.8 0.2 0 (31.0) 1 665.0 330.0 5 254.0 72.0 181.0 116.0 1 343.0 (536.0) (329.0) (66.0)
Other Assets 0 0 0 0 0 1 K 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 691.2 165.1 306.3 425.7 353.3 16.4 8.3 11 771.0 13 053.0 11 539.0 11 232.0 5 291.0 4 535.0 4 127.0 10 013.0 10 953.0 14 213.0 13 221.0
LIABILITIES
Accounts Payable 6.6 22.9 5.3 4.0 3.4 1.3 0.5 367.0 332.0 292.0 216.0 329.0 112.0 15.0 134.0 181.0 303.0 292.0
Short Term Debt 4.8 4.7 9.2 7.8 0 0 0 105.0 201.0 83.0 31.0 13.0 29.0 4.0 148.0 807.0 64.0 51.0
Other Current Liabilities 30.8 23.4 13.6 16.9 7.5 1.1 0.2 506.0 375.0 405.0 410.0 5.0 110.0 135.0 1 271.0 853.0 1 329.0 611.0
Total Current Liabilities 42.3 51.1 28.1 28.7 11.0 2.4 0.7 1 049.0 916.0 812.0 681.0 721.0 347.0 159.0 1 565.0 1 847.0 1 702.0 999.0
Long Term Debt 0 22.7 51.7 57.5 0 0 3.4 8 328.0 8 778.0 7 206.0 7 075.0 1 979.0 1 386.0 584.0 4 426.0 807.0 64.0 51.0
Deferred Tax Income 0 0 0 0 0 0 0 7.0 5.0 29.0 20.0 100.0 95.0 5.0 641.0 0 0 0
Other Liabilities 0 0 (25.9) (28.7) 0 42 K 9.1 146.0 170.0 183.0 217.0 178.0 257.0 145.0 336.0 359.0 500.0 388.0
Total Liabilities 61.4 73.8 54.0 57.5 11.0 2.4 13.1 9 870.0 11 011.0 8 618.0 8 209.0 3 081.0 2 032.0 3 015.0 7 267.0 7 974.0 9 728.0 8 692.0
EQUITY
Common Stock 10 K 6 K 6 K 6 K 5 K 1 K 1 K 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 6.0 5.0 5.0
Retained Earnings (949.9) (632.5) (396.6) (228.5) (79.2) (19.7) (4.9) (1 851.0) (1 927.0) (686.0) (736.0) (463.0) (107.0) (4 841.0) (3 196.0) 0 0 0
Other Accumulative Comprehensive Income/Loss 6 K 0 (0.6) (0.3) 27 K 0 24 K 32.0 21.0 19.0 20.0 58.0 11.0 (53.0) (53.0) (150.0) (215.0) (25.0)
Total Equity 629.8 91.3 252.4 368.2 342.4 14.0 (4.9) 1 901.0 2 042.0 2 921.0 3 023.0 2 210.0 2 503.0 1 112.0 2 746.0 2 902.0 4 515.0 4 506.0
Total Liabilities and Equity 691.2 165.1 306.3 425.7 353.3 16.4 8.3 11 771.0 13 053.0 11 539.0 11 232.0 5 291.0 4 535.0 4 127.0 10 013.0 10 953.0 14 213.0 13 221.0
SHARES OUTSTANDING
Common Shares Outstanding 94.1 59.7 52.0 50.9 14.4 45.4 10.3 162.0 129.0 125.0 126.0 100.0 100.0 122.0 120.0 1 009.6 870.0 1 760.0